Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 229

1.

Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals.

Martin B, Hirota K, Cua DJ, Stockinger B, Veldhoen M.

Immunity. 2009 Aug 21;31(2):321-30. doi: 10.1016/j.immuni.2009.06.020. Epub 2009 Aug 13.

2.

Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.

Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, Mills KH.

Immunity. 2009 Aug 21;31(2):331-41. doi: 10.1016/j.immuni.2009.08.001. Epub 2009 Aug 13.

3.

Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells.

Ramirez JM, Brembilla NC, Sorg O, Chicheportiche R, Matthes T, Dayer JM, Saurat JH, Roosnek E, Chizzolini C.

Eur J Immunol. 2010 Sep;40(9):2450-9. doi: 10.1002/eji.201040461.

4.

IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways.

Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, Levy DE, Leonard WJ, Littman DR.

Nat Immunol. 2007 Sep;8(9):967-74. Epub 2007 Jun 20.

PMID:
17581537
5.

Interleukin-23 is critical for full-blown expression of a non-autoimmune destructive arthritis and regulates interleukin-17A and RORgammat in gammadelta T cells.

Cornelissen F, Mus AM, Asmawidjaja PS, van Hamburg JP, Tocker J, Lubberts E.

Arthritis Res Ther. 2009;11(6):R194. doi: 10.1186/ar2893. Epub 2009 Dec 17.

6.

The Th17/Treg imbalance in patients with acute coronary syndrome.

Cheng X, Yu X, Ding YJ, Fu QQ, Xie JJ, Tang TT, Yao R, Chen Y, Liao YH.

Clin Immunol. 2008 Apr;127(1):89-97. doi: 10.1016/j.clim.2008.01.009. Epub 2008 Feb 21. Erratum in: Clin Immunol. 2009 Dec;133(3):447.

PMID:
18294918
7.

Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion.

Rachitskaya AV, Hansen AM, Horai R, Li Z, Villasmil R, Luger D, Nussenblatt RB, Caspi RR.

J Immunol. 2008 Apr 15;180(8):5167-71.

8.

Modulation of Th17 development and function by activation of the aryl hydrocarbon receptor--the role of endogenous ligands.

Stockinger B, Veldhoen M, Hirota K.

Eur J Immunol. 2009 Mar;39(3):652-4. doi: 10.1002/eji.200839134.

9.

Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22.

Takatori H, Kanno Y, Watford WT, Tato CM, Weiss G, Ivanov II, Littman DR, O'Shea JJ.

J Exp Med. 2009 Jan 16;206(1):35-41. doi: 10.1084/jem.20072713. Epub 2008 Dec 29.

10.

Protective role of naturally occurring interleukin-17A-producing γδ T cells in the lung at the early stage of systemic candidiasis in mice.

Dejima T, Shibata K, Yamada H, Hara H, Iwakura Y, Naito S, Yoshikai Y.

Infect Immun. 2011 Nov;79(11):4503-10. doi: 10.1128/IAI.05799-11. Epub 2011 Aug 29.

11.

Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells.

Gu Y, Yang J, Ouyang X, Liu W, Li H, Yang J, Bromberg J, Chen SH, Mayer L, Unkeless JC, Xiong H.

Eur J Immunol. 2008 Jul;38(7):1807-13. doi: 10.1002/eji.200838331.

12.

CCR6 and NK1.1 distinguish between IL-17A and IFN-gamma-producing gammadelta effector T cells.

Haas JD, González FH, Schmitz S, Chennupati V, Föhse L, Kremmer E, Förster R, Prinz I.

Eur J Immunol. 2009 Dec;39(12):3488-97. doi: 10.1002/eji.200939922.

13.

T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma.

Yang XO, Pappu BP, Nurieva R, Akimzhanov A, Kang HS, Chung Y, Ma L, Shah B, Panopoulos AD, Schluns KS, Watowich SS, Tian Q, Jetten AM, Dong C.

Immunity. 2008 Jan;28(1):29-39. doi: 10.1016/j.immuni.2007.11.016. Epub 2007 Dec 27.

14.

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR.

Cell. 2006 Sep 22;126(6):1121-33.

15.

IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo.

Sonderegger I, Kisielow J, Meier R, King C, Kopf M.

Eur J Immunol. 2008 Jul;38(7):1833-8. doi: 10.1002/eji.200838511.

16.

Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells.

Veldhoen M, Hirota K, Christensen J, O'Garra A, Stockinger B.

J Exp Med. 2009 Jan 16;206(1):43-9. doi: 10.1084/jem.20081438. Epub 2008 Dec 29.

17.

Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells.

Trifari S, Kaplan CD, Tran EH, Crellin NK, Spits H.

Nat Immunol. 2009 Aug;10(8):864-71. doi: 10.1038/ni.1770. Epub 2009 Jul 5.

PMID:
19578368
18.

Vdelta1 T lymphocytes producing IFN-gamma and IL-17 are expanded in HIV-1-infected patients and respond to Candida albicans.

Fenoglio D, Poggi A, Catellani S, Battaglia F, Ferrera A, Setti M, Murdaca G, Zocchi MR.

Blood. 2009 Jun 25;113(26):6611-8. doi: 10.1182/blood-2009-01-198028. Epub 2009 Apr 24.

19.

Human T cells that are able to produce IL-17 express the chemokine receptor CCR6.

Singh SP, Zhang HH, Foley JF, Hedrick MN, Farber JM.

J Immunol. 2008 Jan 1;180(1):214-21.

20.

CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC.

Maggi L, Santarlasci V, Capone M, Peired A, Frosali F, Crome SQ, Querci V, Fambrini M, Liotta F, Levings MK, Maggi E, Cosmi L, Romagnani S, Annunziato F.

Eur J Immunol. 2010 Aug;40(8):2174-81. doi: 10.1002/eji.200940257.

Supplemental Content

Support Center